TMSP(SH:600671) Zheng Xing Xing Ye Ri Bao·2025-10-13 12:38Market Overview - The Chinese traditional medicine sector experienced a decline of 0.93% on October 13, with Tianmu Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3889.5, down 0.19%, while the Shenzhen Component Index closed at 13231.47, down 0.93% [1] Stock Performance - Notable gainers in the traditional medicine sector included: - Wanbangde (002082) with a closing price of 14.40, up 7.22% and a trading volume of 520,800 shares, totaling 715 million yuan [1] - Zoli Pharmaceutical (300181) closed at 18.45, up 1.43% with a trading volume of 150,300 shares, totaling 275 million yuan [1] - Conversely, Tianmu Pharmaceutical (600671) saw a significant decline of 5.17%, closing at 18.16 with a trading volume of 62,800 shares [2] Capital Flow - The traditional medicine sector saw a net outflow of 218 million yuan from institutional investors, while retail investors contributed a net inflow of 133 million yuan [2] - The table of capital flow indicates that Zoli Pharmaceutical had a net inflow of 25.85 million yuan from institutional investors, while retail investors had a net outflow of 21.56 million yuan [3] Summary of Key Stocks - Zoli Pharmaceutical (300181) had a net inflow of 25.85 million yuan from institutional investors, but a net outflow of 21.56 million yuan from retail investors [3] - Tianmu Pharmaceutical (600671) experienced a net inflow of 6.41 million yuan from retail investors, despite a significant overall decline [3]